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Abstract
In 2017, the EFSA Panel on Additive and Products or Substances used in Animal Feed (FEEDAP)
delivered a scientiﬁc opinion on the safety and efﬁcacy of Probion Forte® (Bacillus subtilis KCCM
10941P and Bacillus coagulans KCCM 11093P) as a feed additive for chickens for fattening. The two
bacterial species are considered suitable for the qualiﬁed presumption of safety (QPS) approach to
safety assessment provided that the identity of the strains is established and the lack of toxigenic
potential and acquired antimicrobial resistance for antibiotics of human and veterinary importance are
demonstrated. In that opinion, the FEEDAP Panel was unable to conclude on the safety and efﬁcacy of
the additive due to inadequacy of the data available. In the current dossier, the applicant submitted a
new cytotoxicity study in support to the safety of the active agents, a new skin sensitisation study and
three new efﬁcacy trials performed with chickens for fattening. The FEEDAP Panel identiﬁed a
limitation in the experimental design of the cytotoxicity study which did not allow excluding the
possible toxigenic potential of the strains. One of the three efﬁcacy trials was not considered due to
the high mortality (including culling) reported in the control group. On the basis of the data available,
the FEEDAP Panel could not conclude on the safety of Probion Forte® for the target species and for
the consumer. Probion Forte® was not considered a skin sensitiser. The FEEDAP Panel could not
conclude on the efﬁcacy of Probion Forte® for chickens for fattening.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
Regulation (EC) No 1831/20031 established rules governing the Community authorisation of
additives for animal nutrition and, in particular, Article 9 deﬁnes the terms of the authorisation by the
Commission.
The applicant, Agencja Inwestycyjno-Handlowa B&B dr ini. Zbigniew Borowski, is seeking a
Community authorisation of Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P as a
feed additive to be used as a gut ﬂora stabiliser for laying hens, chickens for fattening and chickens
reared for lying. (Table 1)
On 06 April 2017, the Panel on Additives and Products or Substances used in Animal Feed of the
European Food Safety Authority (“Authority”), in its opinion, on the safety and efﬁcacy of the product,
could not conclude on the safety of Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM
11093P as a feed additive for laying hens, chickens for fattening and chickens reared for laying due to
the toxigenic potential.
The Commission gave the possibility to the applicant to submit complementary information in order
to complete the assessment and to allow a revision of Authority’s opinion. The new data have been
received on 17 October 2018.
In view of the above, the Commission asks the Authority to deliver a new opinion on Bacillus
subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P as a feed additive for lying hens, chickens
for fattening and chickens reared for laying based on the additional data submitted by the applicant.
1.2. Additional information
The EFSA Panel on Additive and Products or Substances used in Animal Feed (FEEDAP), in 2017,
delivered a scientiﬁc opinion on the safety and efﬁcacy of Probion Forte® (Bacillus subtilis KCCM
10941P and Bacillus coagulans KCCM 11093P) as a feed additive for chickens for fattening (EFSA
FEEDAP Panel, 2017). In that opinion, the FEEDAP Panel was unable to conclude on the safety and
efﬁcacy of the additive due to inadequacy of the data available.
2. Data and methodologies
2.1. Data
The present assessment is based on the data submitted by the applicant in the form of additional
information2 following a previous application on the same product.3
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety of Probion Forte® (Bacillus subtilis
KCCM 10941P and Bacillus coagulans KCCM 11093P) is in line with the principles laid down in
Regulation (EC) No 429/20084 and the relevant guidance documents: Guidance on the characterisation
of microorganisms used as feed additives or as production strains (EFSA FEEDAP Panel, 2018a),
Table 1: Description of the substances
Category of additive Zootechnical additive
Functional group of additive Gut ﬂora stabilisers
Description Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM11093P
Target animal category Laying hens, chickens for fattening and chickens reared for laying
Applicant Agencja Inwestycyjno – Handlowa B&B dr ini. Zbigniew Borowski
Type of request New application
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Dossier reference: FAD-2018-0076.
3 Dossier reference: FAD-2014-0038.
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
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Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP
Panel, 2012) and Guidance on the assessment of the efﬁcacy of feed additives (EFSA FEEDAP Panel,
2018b).
3. Assessment
Probion Forte® is a preparation of spores of B. subtilis and B. coagulans. The additive is intended
to be used as a zootechnical additive (functional group: gut ﬂora stabiliser) in feed for chickens for
fattening at the minimum recommended level of 1 9 108 colony forming unit (CFU)/kg (equivalent to
500 mg/kg feedingstuffs) and a maximum level of 2 9 108 CFU/kg feedingstuffs (equivalent to
1,000 mg/kg feedingstuffs).
In the original application, the applicant requested the use of the additive in chickens for fattening,
chickens reared for laying and laying hens; however, during the course of that assessment, the
applicant requested to limit the scope of the application to chickens for fattening only.
The applicant, in the current application, has submitted a new cytotoxicity study in support to the
safety of the active agents, a new skin sensitisation study and three new efﬁcacy trials performed with
chickens for fattening. These studies aim at fulﬁlling the gaps identiﬁed in the previous assessment of
the additive (EFSA FEEDAP Panel, 2017).
3.1. Characterisation
The additive was fully characterised in the previous opinion in terms of physico-chemical properties,
purity, technological properties and manufacturing process (EFSA FEEDAP Panel, 2017).
3.1.1. Characterisation of the active agents
In its previous opinion, the FEEDAP Panel assessed a cytotoxicity study performed on ﬁbroblast
cells and concluded that, due to some limitations (i.e. unknown test item, inappropriate negative and
positive controls, inappropriate cell line used), the study was not acceptable as a mean of excluding
the toxigenic potential of the two strains (EFSA FEEDAP Panel, 2017).
In the current dossier, the applicant submitted a new cytotoxicity study using epithelial cell line
(Vero cells) in order to demonstrate the absence of a toxigenic potential of the strains.5 Cytotoxicity
was measured by means of a lactate dehydrogenase (LDH) assay in accordance to the EFSA ‘Guidance
on the assessment of the toxigenic potential of Bacillus species used in animal nutrition’ (EFSA FEEDAP
Panel, 2014). However, the study was performed without an adequate positive control. This limitation
in the experimental design does not allow the FEEDAP Panel to exclude the possible toxigenic potential
of the strains.
3.2. Safety
3.2.1. Safety for the target species and for the consumer
The two bacterial species are considered suitable for the qualiﬁed presumption of safety (QPS)
approach to safety assessment provided that the identity of the strains is established and the lack of
toxigenic potential and acquired antimicrobial resistance for antibiotics of human and veterinary
importance are demonstrated. In the previous opinion, the identity of the two active agents was
established and the lack of acquired antimicrobials determinants conﬁrmed. However, since the
absence of toxigenic potential was not demonstrated, these strains did not comply with the QPS
qualiﬁcation to safety assessment. Consequently, they could not be presumed safe for the target
species and consumers of products derived from animals treated with the additive without additional
studies (EFSA FEEDAP Panel, 2017).
The applicant did not provide data to ﬁll the gap identiﬁed in the previous opinion. Therefore, in
the absence of evidence that the two strains are not toxigenic, the safety of the additive for the target
species and for the consumer cannot be established.
5 Technical dossier/cytotoxicity_study.
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3.2.2. Safety for the user
In its previous opinion, the FEEDAP Panel assessed an acute dermal irritation study and an acute
eye irritation study and concluded that Probion Forte® was not a skin or eye irritant. In the absence
on data, no conclusion could be drawn on the skin sensitisation potential. Moreover, the additive was
considered a potential respiratory sensitiser. In the absence of evidence that the two active agents are
not toxigenic, Probion Forte® is considered as a respiratory hazard for those handling the additive
(EFSA FEEDAP Panel, 2017).
In the current dossier, the applicant provided a new skin sensitisation study6 performed in
accordance to the OECD Guideline 406. Probion Forte® did not show any skin sensitisation potential.
3.2.3. Safety for the environment
The strains composing the additive belong to species which are ubiquitous soil saprophytes.
Consequently, use of the strains in animal nutrition is not expected to measurably increase their
numbers in the environment. Therefore, its use as a feed additive is considered safe for the
environment (EFSA FEEDAP Panel, 2017).
3.3. Efﬁcacy for chickens for fattening
In its previous opinion, the FEEDAP Panel assessed six trials in support of the efﬁcacy of Probion
Forte® when used in chickens for fattening (EFSA FEEDAP Panel, 2017). Due to some limitations in the
experiments and to the incomplete reporting of some experimental details, the FEEDAP Panel was
unable to conclude on the efﬁcacy of the additive when used in chickens for fattening.
In the current dossier, the applicant submitted three new efﬁcacy trials. However, one of the trials
was not further considered due to the high mortality (including culling) in the control group (11%).
The two trials considered were done in the same trial site and followed the same trial design. In
each trial, a total of 480 one-day-old male chickens for fattening (Ross 308) were distributed in 60
ﬂoor pens in groups of eight animals and allocated to three dietary treatments (20 replicates per
treatment) for 42 days.7,8 Three basal mash diets (starter, grower and ﬁnisher) based on soybean
meal (SBM) 44% crude protein (CP), maize, wheat, rapeseed meal, lard and soy oil were either not
supplemented (control) or supplemented with Probion Forte® to provide 0, 500 or 1,000 mg additive/
kg feed, corresponding to 0, Bacillus subtilis 0.58 9 108/Bacillus coagulans 0.56 9 108 CFU/kg feed
and Bacillus subtilis 1.17 9 108/Bacillus coagulans 1.12 9 108 CFU/kg, respectively.
Mortality and health status were monitored daily. Animals were weighed on days 0, 11, 21 and end
(pen basis), feed intake was registered per pen and feed to gain ratio calculated. An analysis of
variance (ANOVA) was done with the performance data (pen basis) and considering the treatment as
the effect. Group means were compared with the Duncan test. Mortality was analysed using the
Kruskall–Wallis method. The signiﬁcance level was set at 0.05.
The results are presented in Table 2. Birds receiving the additive had a higher body weight
compared to the control in the two trials, one at the lowest recommended dose and one at the highest
dose. A signiﬁcant better feed to gain ratio was observed compared to the control at the lowest
recommended level in one of the trials (trial 1).
Table 2: Effects of Probion Forte® on the performance of chickens for fattening
Study No
Treatment groups Total feed
intake
per animal
(g)
Final body
weight
(g)
Feed to gain
ratio
Mortality and
culling
% (n.)
CFU/kg
feed
mg/kg
feed
1 0 0 4,146 2,672b 1.55a 1.3 (2)
1 9 108 500 4,136 2,780a 1.49b 0.6 (1)
2 9 108 1,000 4,227 2,813a 1.50b 1.9 (3)
6 Technical dossier/Skin Sensitization_Study.
7 Technical dossier/Probion-Forte_Study1.
8 Technical dossier/Probion-Forte_Study3.
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3.3.1. Conclusions on efﬁcacy for the target species
The FEEDAP Panel, in the absence of a third trial showing positive effects of the additive on the
performance of the birds, cannot conclude on the efﬁcacy of Probion Forte® in chickens for fattening.
4. Conclusions
The absence of toxigenic potential of the strains (B. subtilis KCCM 10941P and B. coagulans KCCM
11093P) has not been demonstrated, and therefore, the qualiﬁcations for the QPS approach were not
met. On the basis of the data submitted by the applicant, the FEEDAP Panel cannot conclude on the
safety of Probion Forte® for the target species and for the consumer.
The new data evaluated indicate that Probion Forte® is not a skin sensitiser. In the absence of
evidence that the two active agents are not toxigenic, Probion Forte® is considered as a respiratory
hazard for those handling the additive.
The FEEDAP Panel cannot conclude on the efﬁcacy of Probion Forte® for chickens for fattening.
Documentation provided to EFSA
1) Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P. October 2018.
Submitted by Agencja Inwestycyjno on the behalf of WooGene B&B Co.,Ltd.
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Study No
Treatment groups Total feed
intake
per animal
(g)
Final body
weight
(g)
Feed to gain
ratio
Mortality and
culling
% (n.)
CFU/kg
feed
mg/kg
feed
2 0 0 3,766 2,433b 1.55 0.65 (3)
1 9 108 500 3,754 2,479b 1.52 0.41 (2)
2 9 108 1,000 3,778 2,590a 1.46 0.82 (4)
CFU: colony forming unit.
a,b: Mean values within a column with a different superscript are signiﬁcantly different p < 0.05.
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Abbreviations
ANOVA analysis of variance
CFU colony forming unit
CP crude protein
FEEDAP Panel on Additives and Products or Substances used in Animal Feed
LDH lactate dehydrogenase
SBM soybean meal
QPS qualiﬁed presumption of safety
Probion forte® for chickens for fattening
www.efsa.europa.eu/efsajournal 8 EFSA Journal 2019;17(3):5644
